Naboso

Sensory products to optimise movement

Naboso

Sensory products to optimise movement

Chandler, AZ
Health Tech
Consumer Products
Naboso has developed a proprietary textured material that has proven to have an instantaneous effect on enhancing movement. Using their unique material, they’ve manufactured sensory insoles, mats, and flooring — all of which activate the nervous system through stimulation of the feet. While continuing to innovate within the health and wellness space, Naboso continues to positively impact the lives of those living with chronic neurological conditions along with elite level athletes and everyone in-between.

$199,976

raised
285
Investors
$9.88M
Valuation
$0.81
Price per Share
$149.04
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
Reg CF
Offering

$199,976

raised
285
Investors
$9.88M
Valuation
$0.81
Price per Share
$149.04
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
Reg CF
Offering

Rewards

Get rewarded for investing more into Naboso:

$149+
Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$250+
Investment
Tier 1 perk
($250 + Pair of Duo Insoles)
$500+
Investment
Tier 2 perk
($500 + Pair of Duo Insoles + Neuro Ball)
$1,000+
Investment
Tier 3 perk
($1000 + Pair of Duo Insoles + NeuroBall + 25% off sitewide 2x a year)
$5,000+
Investment
Tier 4 perk
($5,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year)
$10,000+
Investment
Tier 5 perk
($10,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 5% bonus shares)
$25,000+
Investment
Tier 6 perk
($25,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 10% bonus shares)
$50,000+
Investment
Tier 7 perk
($50,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 15% bonus shares)

Reasons to Invest

68% revenue growth over the past year during a global pandemic. Naboso has global distribution in 9 countries, and oversees direct-to-consumer sales throughout the U.S. and Europe, with continued product innovations and partnership licensing.
Innovative textured product lines have proven to increase balance, gait, strength, stability, and posture with applications in medical, wellness and performance.
Founded by a renowned podiatrist and global leader in barefoot training and rehabilitation with many media appearances including ​The Today Show​, ​The Oprah Winfrey Show​, and ​The Doctors​.

Overview


Innovative products backed by texture science that change the way people move, instantly

Naboso has developed a proprietary textured material that instantly strengthens the neurological connection between one’s brain and their feet. This sensory material serves as the foundation for a variety of products that optimize movement from the ground up, all while promoting maximum body awareness and muscle recruitment. 

Whether you are an elite athlete, someone living with a chronic neurological condition like neuropathy, or an individual working on their feet all day long, Naboso’s products are here to keep you connected to your foundation. 

The Problem


The footwear and insole markets are ruining more than just feet

Feet were never meant to be crammed into narrow shoes, smashed down into cushioned soles and disconnected from the sensory stimulation of each step we take. Inhibiting toe spread, along with the reduction of foot sensation over time, can lead to foot pain, deformities, movement disorders, and postural and muscular imbalances.


Meanwhile, the insole market continues to focus on artificial arch support and cushion, both of which are often short-term solutions that lead to greater muscular compensations and a disconnect from our feet. As a result, we are improperly positioning our feet and overlooking one of the most important factors for foot strength and body coordination: sensory stimulation.  

With sensory stimulation as the foundation to movement, current footwear and insoles actually contribute to a sensory disconnect between the body and the ground we walk on. This sensory disconnect has been shown to contribute to atrophy of foot muscles, poor posture and even increases fall risk. 

The Solution


An instant brain and body connection that starts at your feet

It's time to bring the power of barefoot back into footwear and insoles. With Naboso's proprietary textured product line, feet are now able to stay stimulated regardless of the footwear or environment we are in. As the only sensory product line on the market, Naboso is helping to awaken the areas of the brain that allow for an instantaneous increase in neuro-muscular control. By increasing the neurological connection between the brain and the body’s foundation, Naboso enhances movement and body control.

Why Invest


Naboso has created an entirely new category that is changing lives through movement

Founded by passion for the health and wellness of others, Naboso is unlike any other insole or mat on the market. Led by a Functional Podiatrist with a deep understanding of texture science and the benefits of foot stimulation, Naboso’s approach is simple: Stimulate the feet. Activate the brain. Utilize more of the body. 

Customers from NASA, FYZICAL Balance Centers, and the MS Mandell Center are experiencing the powerful effects of foot stimulation and the Naboso textured product line. Patients at these centers are experiencing the power of sensory input and agree that Movement is life, and life is sensory.

The Market


Accessing several industries on the rise with the use of texture science

There are over 20 million adults in the US living with neuropathy or the inability to feel their feet (source), 43 million Americans who report experiencing foot pain every year (source), and approximately 65% of employees report prolonged standing at work causing over $2.6 billion in associated ergonomic health care costs (source). 

The global insole market is on its way to reaching $3.68 billion (source), with diabetes and the aging population as the biggest drivers to this market growth.

In addition, the global footwear industry is worth $365 billion (source); all of which Naboso fits into. 

TRACTION LED BY PROVEN RESULTS 


Naboso makes a difference

A 2020 Stanley Black & Decker pilot study showed that standing employees who wore Naboso insoles for six weeks experienced a 93% decrease in reported foot pain, 78% decrease in reported back pain, and 87% decrease in reported musculoskeletal fatigue. This was all associated with a reported 77% increase in productivity. 

In the past year Naboso had 68% growth in revenue, as well as expansion into the European and Asian markets, and the launch of two new product innovations. Naboso has global distribution in nine regions and sells direct to consumers through a newly designed e-commerce platform in the U.S., across Europe, and, starting February 2021, in Australia. 


The power of Naboso is not only in their textured product line but also in the licensing opportunities of their proprietary material. With 5 license agreements including Xero Shoes, Power Plate, True Form Runner, BodiTrak and RAD Roller, the impact of Naboso is outreaching their network within medical, wellness and performance.

WHAT NABOSO DOES 


Increasing strength, balance, posture, and gait starting in the sole

The brain can only control what it’s connected to. Using the Naboso product line to stimulate the bottom of the feet keeps your body and brain connected. An increase in foot and body awareness allows for optimal movement and puts you in control of your full potential. Optimized movement is for everyone, and so is Naboso.

The Business Model


Selling direct to consumer and business to business

The Naboso product portfolio is comprised of 5 insoles, 4 mats, a newly launched release ball, floor paneling, and texture sheets that are currently sold to orthotic labs. In addition to Naboso manufactured products, there are also five licensed product collaborations with companies such as Xero Shoes, TrueForm Runner, RAD Roller, Boditrak, and Power Plate. 

DTC accounts for 60% of sales revenue. Naboso’s newly designed website and e-commerce platform is increasing sales in the US and Europe, and products are also available for purchase on Amazon in the US, Canada, and Europe. Selling direct to consumer allows for a 94% profit margin on insoles, and 69% for mats.

BTB accounts for 40% of sales revenue. Naboso products are sold to retailers, resellers, and distributors across North America, Europe, Asia, and Australia. Selling business to business allows for an 88% profit margin on insoles, and 55% on mats. 

The Vision


Change lives with movement

Naboso is redefining how the world perceives the foot, and will continue to educate the benefits of sensory science and texture stimulation. Naboso has one goal: enable people to move in their highest capacity for as long as possible, during any life stage. 

Whether you are treating an ailment, going through recovery, living with an acute or chronic neurological disorder, on your feet for extended periods of time, hitting your next training session, or preparing for a big game, movement is life, and Naboso is there every step of the way.

OUR LEADERSHIP


Podiatrist. Entrepreneur. Founder.

Founder of Naboso, Dr. Emily Splichal has been traveling the world to share her unique approach to human movement, foot function, and barefoot science. Having taught 25,000 professionals in 40 countries, Dr. Splichal has quickly become a global leader in barefoot training and rehabilitation.

In addition to industry leadership, Dr. Splichal has a strong media presence and has appeared on The Today Show, The Oprah Winfrey Show, The Doctors, HSN, The New Yorker, The L A Times, and Shape Magazine. 

In the Press

CIVILIAN MAGAZINE
January 1, 2017

Healthy Designed for Home

Athletics Weekly
January 1, 2017

A Helping Hand

Digital Trends
January 1, 2017

Insoles claim to fight Parkinson’s symptoms by stimulating nerves in your feet

Athletic Business

Naboso Technology and TrueForm Runner Launch the First and Only Proprioceptive Treadmill for Rehabilitation and Performance

Multiple Sclerosis New Today

New Products Intended to Stimulate Feet of MS Patients

Offering Summary


Company

:

Naboso Technology, Inc.

Corporate Address

:

6825 W Galveston Street Suite 9 , Chandler, AZ 85226

Offering Minimum

:

$9,999.45

Offering Maximum

:

$1,069,998.66

Minimum Investment Amount

(per investor)

:

$149.04











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

12,345

Maximum Number of Shares Offered

:

1,320,986

Price per Share

:

$0.81

Pre-Money Valuation

:

$9,882,000.00











COVID Relief

This offering is being conducted on an expedited basis due to circumstances relating to COVID-19 and pursuant to the SEC’s temporary regulatory COVID-19 relief set out in Regulation Crowdfunding §227.201(z).

Expedited closing sooner than 21 days

Further, in reliance on Regulation Crowdfunding §227.303(g)(2) A funding portal that is an intermediary in a transaction involving the offer or sale of securities initiated between May 4, 2020, and February 28, 2021, in reliance on section 4(a)(6) of the Securities Act (15 U.S.C. 77d(a)(6)) by an issuer that is conducting an offering on an expedited basis due to circumstances relating to COVID-19 shall not be required to comply with the requirement in paragraph (e)(3)(i) of this section that a funding portal shall not direct transmission of funds earlier than 21 days after the date on which the intermediary makes publicly available on its platform the information required to be provided by the issuer under §§227.201 and 227.203(a).

*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Company Perks*

Early Bird (first 72 hours)

Friends and Family - First 24 hours | 15% bonus shares

Super Early Bird - Next 24 hours | 10% bonus

Early Bird Bonus - Next 24 hours | 5% bonus shares

Volume

Tier 1 perk - ($250 + Pair of Duo Insoles)

Tier 2 perk - ($500 + Pair of Duo Insoles + Neuro Ball) 

Tier 3 perk - ($1000 + Pair of Duo Insoles + NeuroBall + 25% off sitewide 2x a year)

Tier 4 perk - ($5,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year)

Tier 5 perk - ($10,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 5% bonus shares)

Tier 6 perk - ($25,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 10% bonus shares)

Tier 7 perk - ($50,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 15% bonus shares)

*All perks that occur when the offering is complete must be added right below the company perks.

The 10% StartEngine Owners' Bonus

Naboso will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of common stock at $0.81 / share, you will receive 110 shares of common stock, meaning you'll own 110 shares for $81. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

The Company will not incur any irregular use of proceeds.


Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$584,336.00 USD
$185,870.00 USD
Cash And Cash Equivalents
$62,014.00 USD
$33,799.00 USD
Accounts Receivable
$10,178.00 USD
$8,955.00 USD
Short Term Debt
$333,729.00 USD
$46,251.00 USD
Long Term Debt
$200,916.00 USD
$51,008.00 USD
Revenues And Sales
$773,882.00 USD
$461,172.00 USD
Costs Of Goods Sold
$241,485.00 USD
$125,562.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$44,920.00 USD
-$9,949.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Notice of Funds Disbursement

16 hours ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Naboso has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Naboso be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Naboso Parkinson's Study - IRB Approved!

1 day ago

Thank you to all our investors and those following Naboso, considering to invest. 

We wanted to share the update that Hartford Healthcare just received IRB approval to conduct a randomized control trial to study Naboso Neuro Insoles with Parkinson's disease. 

This study will look at foot sensitivity and gait changes over a 30 day period when integrating Naboso Insoles vs.smooth insoles. 

***

This is just one of the many studies Naboso is initiating throughout 2021 with the end goal of increasing validation in the neuro rehab space and getting FDA Approval as a class 2 device for neuropathy. 

Your investment will play a pivotal role in this step! 

Thank you again, 

Dr Emily Splichal, CEO 

Over $90k raised in first 24 hours!

12 days ago

It is with strong moment that Naboso kicked off its first crowd equity campaign hitting an awesome investment milestone of over $90k in the first 24 hours.    


To all who have invested thus far we are very grateful for your support in Naboso's mission and vision to optimize movement from a sensory perspective.      


Stay tuned for continued updates during our investment journey and don't forget that movement is life, and life is sensory 


Dr Emily Splichal, CEO + Co-Founder 

Naboso 

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}